Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Freenome

Biotech & Life Sciences · San Francisco, United States · Founded 2014 Unicorn

A health technology company developing accurate, accessible and non-invasive disease screening products

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$100–500M
Latest reported FY
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Investors

48 investors on Freenome's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 5 investors entered at this stage
Andreessen Horowitz
Founders Fund
Loxbridge Research
Third Kind Venture Capital
DCVC
Series A 9 investors entered at this stage
Series B+ 34 investors entered at this stage
HBM Healthcare Investments
Artis Ventures
Perceptive Advisors
Sands Capital Management
Eventide Asset Management
The Colon Cancer Alliance
Squarepoint Capital
Rock Springs Capital
Kaiser Permanente
Fidelity Investments
ARK Invest
Roche
Janus Henderson Investors
Byers Capital
Kaiser Permanente Ventures
RA Capital Management
Bain Capital Life Sciences
EcoR1 Capital
T. Rowe Price
Farallon Capital Management
Pura Vida Investments
Catalio Capital Management
Cormorant Capital
Suvretta Capital Management
Soleus Capital
Logos Capital
Quest Diagnostics
Roche Venture Fund
Intermountain Ventures
BrightEdge
Ridgeback Capital
Novartis
Cormorant Asset Management
ArrowMark Partners

Ownership

Who owns Freenome

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

32.5% Roche

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Freenome has talent and traffic

Workforce by country
8 countries with
team presence
🇺🇸 United States96.2%
🇬🇧 United Kingdom1%
🇨🇦 Canada0.6%
🇨🇭 Switzerland0.6%
🇦🇹 Austria0.6%
Top 5 of 8 shown
Web traffic by country
26K monthly visits
across markets
🇺🇸 United States63.5%
🇨🇦 Canada10%
🇮🇳 India7.3%
🇬🇧 United Kingdom5.8%
🇵🇭 Philippines2.3%
Top 5 markets shown

Talent graph

The shape of Freenome's talent

Dealroom maps Freenome's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

15 standout operatorsDealroom-flagged across the org
14 AI specialistsincl. 9 core researchers
392 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Freenome's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$6M patent portfolio · 23 active families

Estimated portfolio value
$6M
0.43% of valuation · 2.8× larger than top peer Owkin ($2M)
23 active patent families
Where Freenome innovates BioinformaticsComputational biologyPathologyCellMolecular biology

Where Freenome concentrates vs peers

Each axis is a top-10 topic across Freenome and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Freenome

An AI-synthesized read of the highest-engagement posts about Freenome on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Freenome on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.